Print

Projects

Radiopharmaceuticals Research

In vivo molecular imaging allows researchers and clinicians to probe biochemical interactions using specific radiolabelled molecules. The recent advances in computer emission tomography, image reconstruction and animal models of disease provides extremely sensitive and specific tools capable of providing quantitative, spatial and kinetic information on molecular and biological processes in living systems. As a consequence this technology provides the foundation for knowledge that accelerates basic research in the biosciences provides new opportunities to image disease and assist in the selection and evaluation of treatments for patients

RRI research programs focus on the labelling of biologically significant molecules with radioactive isotopes to better understand and treat human diseases, particularly cancer, neurodegeneration, inflammation and diabetes. To achieve this, it is exploiting advances in molecular biology, genomics, proteomics, stem cell technologies, drug development and novel in vivo models of disease.

 

Print this page
Back to original page